MedPath
FDA Approval

Modafinil

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
February 11, 2021
Labeling Type
Human Prescription Drug Label
Modafinil(200 mg in 1 1)

Manufacturing Establishments2

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

APL HEALTHCARE LIMITED

Aurobindo Pharma Limited

650844777

Aurobindo Pharma Limited

Aurobindo Pharma Limited

650381903

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Modafinil

Product Details

NDC Product Code
65862-602
Application Number
ANDA202566
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
February 11, 2021
ModafinilActive
Code: R3UK8X3U3DClass: ACTIBQuantity: 200 mg in 1 1
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT

Modafinil

Product Details

NDC Product Code
65862-601
Application Number
ANDA202566
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
February 11, 2021
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
ModafinilActive
Code: R3UK8X3U3DClass: ACTIBQuantity: 100 mg in 1 1
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
© Copyright 2025. All Rights Reserved by MedPath